Psoriasis Skin Disorder Current Affairs - 2020

‘Itolizumab’ Injection gets DCGI Approval for Treatment of Moderate to Serve ARDS Patients

The Drug Controller General of India (DCGI) has given its approval to ‘Itolizumab’ injection for the treatment of COVID-19 patients with restricted emergency use only in case of moderate to severe Acute Respiratory Distress Syndrome (ARDS) patients. DCGI has made it clear that written informed consent of the patient will be required by the authorities Read More…